Goldman Sachs Group Inc A Ikido Pharma Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,554 shares of AIKI stock, worth $47,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,554Holding current value
$47,705% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIKI
# of Institutions
34Shares Held
1.22MCall Options Held
369KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA346KShares$1.31 Million0.0% of portfolio
-
Connective Capital Management, LLC Palo Alto, CA335KShares$1.27 Million2.18% of portfolio
-
Two Sigma Investments, LP New York, NY109KShares$413,1620.0% of portfolio
-
Geode Capital Management, LLC Boston, MA81KShares$307,9860.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...